A long-term study has identified a potential biomarker that could help detect which patients are progressing toward more severe forms of multiple sclerosis.
A new University of Toronto-led study has discovered a possible biomarker linked to multiple sclerosis (MS) disease ...
A new University of Toronto-led study has discovered a possible biomarker linked to multiple sclerosis (MS) disease ...
Ongoing clinical trials are exploring therapies like tolebrutinib, fingolimod, and ocrelizumab, focusing on efficacy and ...
By analysing MRI scans and a simple blood test from hundreds of patients, researchers identified patterns that reveal how ...
See why TG Therapeutics, Inc. earns a Buy rating, with insights on Briumvi's efficacy and market growth in multiple sclerosis ...
Abstract: Aiming at the problem that the traditional time series prediction model only considers a single node (region), does not take into account the spatial interactivity among multiple nodes and ...
Discover why Biogen Inc.'s stock surged 15% in 2025, driven by Skyclarys sales. Explore its strong growth potential and ...
Abstract: Multiple microphone arrays have many applications in robot audition, including sound source localization, audio scene perception and analysis, etc. However, accurate calibration of multiple ...
Researchers say the more they find out, the more likely 'we will be able to find treatments that can stop disease progression ...
Tiziana reports excellent safety profile with intranasal foralumab after 37.4 patient-years cumulative exposureFDA denial of Sanofi's tolebrutinib for nrSPMS shows need for safe therapy BOSTON, Dec.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback